Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rujietai capsule in breast hyperplasia (phase IV, China)
CTR20211525Phase 4Completed
- Sponsor
- Guangxi Changhong Pharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Rujietai in breast hyperplasia, sponsored by Guangxi Changhong Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
Rujietai
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on CTR20211525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211525.